158 related articles for article (PubMed ID: 27354333)
1. Featured Article: Alterations of lecithin cholesterol acyltransferase activity and apolipoprotein A-I functionality in human sickle blood.
Soupene E; Borja MS; Borda M; Larkin SK; Kuypers FA
Exp Biol Med (Maywood); 2016 Nov; 241(17):1933-1942. PubMed ID: 27354333
[TBL] [Abstract][Full Text] [Related]
2. Featured Article: Depletion of HDL
Soupene E; Larkin SK; Kuypers FA
Exp Biol Med (Maywood); 2017 Jun; 242(12):1244-1253. PubMed ID: 28436274
[TBL] [Abstract][Full Text] [Related]
3. Role of lecithin:cholesterol acyltransferase and apolipoprotein A-I in cholesterol esterification in lipoprotein-X in vitro.
O K; Frohlich J
J Lipid Res; 1995 Nov; 36(11):2344-54. PubMed ID: 8656072
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein subfraction profile and HDL-associated enzymes in sickle cell disease patients.
Ozturk OH; Can Y; Yonden Z; Motor S; Oktay G; Kaya H; Aslan M
Lipids; 2013 Dec; 48(12):1217-26. PubMed ID: 24113910
[TBL] [Abstract][Full Text] [Related]
5. Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
Calabresi L; Simonelli S; Conca P; Busnach G; Cabibbe M; Gesualdo L; Gigante M; Penco S; Veglia F; Franceschini G
J Intern Med; 2015 May; 277(5):552-61. PubMed ID: 25039266
[TBL] [Abstract][Full Text] [Related]
6. A fluorescence method to detect and quantitate sterol esterification by lecithin:cholesterol acyltransferase.
Homan R; Esmaeil N; Mendelsohn L; Kato GJ
Anal Biochem; 2013 Oct; 441(1):80-6. PubMed ID: 23851343
[TBL] [Abstract][Full Text] [Related]
7. Altered HDL particle in sickle cell disease: decreased cholesterol content is associated with hemolysis, whereas decreased Apolipoprotein A1 is linked to inflammation.
Yalcinkaya A; Unal S; Oztas Y
Lipids Health Dis; 2019 Dec; 18(1):225. PubMed ID: 31861992
[TBL] [Abstract][Full Text] [Related]
8. Altered epitope expression of human interstitial fluid apolipoprotein A-I reduces its ability to activate lecithin cholesterol acyl transferase.
Wong L; Curtiss LK; Huang J; Mann CJ; Maldonado B; Roheim PS
J Clin Invest; 1992 Dec; 90(6):2370-5. PubMed ID: 1281832
[TBL] [Abstract][Full Text] [Related]
9. The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase.
Nobecourt E; Davies MJ; Brown BE; Curtiss LK; Bonnet DJ; Charlton F; Januszewski AS; Jenkins AJ; Barter PJ; Rye KA
Diabetologia; 2007 Mar; 50(3):643-53. PubMed ID: 17216278
[TBL] [Abstract][Full Text] [Related]
10. Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased lecithin-cholesterol acyltransferase activation and cellular cholesterol efflux.
Anthanont P; Asztalos BF; Polisecki E; Zachariah B; Schaefer EJ
J Clin Lipidol; 2015; 9(3):390-5. PubMed ID: 26073399
[TBL] [Abstract][Full Text] [Related]
11. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
[TBL] [Abstract][Full Text] [Related]
12. DYRK1A overexpression decreases plasma lecithin:cholesterol acyltransferase activity and apolipoprotein A-I levels.
Tlili A; Noll C; Middendorp S; Duchon A; Jouan M; Benabou E; Hérault Y; Paul JL; Delabar JM; Janel N
Mol Genet Metab; 2013 Nov; 110(3):371-7. PubMed ID: 23920041
[TBL] [Abstract][Full Text] [Related]
13. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
[TBL] [Abstract][Full Text] [Related]
14. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins.
Frank PG; N'Guyen D; Franklin V; Neville T; Desforges M; Rassart E; Sparks DL; Marcel YL
Biochemistry; 1998 Sep; 37(39):13902-9. PubMed ID: 9753480
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of lipid oxidation on the activity of plasma lecithin-cholesterol acyltransferase.
Kamiyama S; Yamato T; Furukawa Y
Biosci Biotechnol Biochem; 1998 May; 62(5):941-6. PubMed ID: 9648224
[TBL] [Abstract][Full Text] [Related]
16. Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase.
Salvatore A; Cigliano L; Bucci EM; Corpillo D; Velasco S; Carlucci A; Pedone C; Abrescia P
Biochemistry; 2007 Oct; 46(39):11158-68. PubMed ID: 17824618
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-I helix 6 negatively charged residues attenuate lecithin-cholesterol acyltransferase (LCAT) reactivity.
Alexander ET; Bhat S; Thomas MJ; Weinberg RB; Cook VR; Bharadwaj MS; Sorci-Thomas M
Biochemistry; 2005 Apr; 44(14):5409-19. PubMed ID: 15807534
[TBL] [Abstract][Full Text] [Related]
18. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
[TBL] [Abstract][Full Text] [Related]
19. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
de Vries R; Borggreve SE; Dullaart RP
Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
[TBL] [Abstract][Full Text] [Related]
20. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
